Tag Archives: KKR

Best Financial Stocks To Invest In Right Now

Divisar Capital Management LLC reduced its position in shares of Zumiez Inc. (NASDAQ:ZUMZ) by 81.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 26,994 shares of the apparel and footwear maker’s stock after selling 120,085 shares during the period. Zumiez comprises approximately 0.2% of Divisar Capital Management LLC’s holdings, making the stock its 26th largest position. Divisar Capital Management LLC’s holdings in Zumiez were worth $676,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. BlackRock Inc. raised its holdings in Zumiez by 3.2% during the second quarter. BlackRock Inc. now owns 2,986,304 shares of the apparel and footwear maker’s stock worth $74,807,000 after purchasing an additional 91,515 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Zumiez by 0.6% during the second quarter. Dimensional Fund Advisors LP now owns 2,143,187 shares of the apparel and footwear maker’s stock worth $53,688,000 after purchasing an additional 12,751 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Zumiez by 1.0% during the second quarter. Massachusetts Financial Services Co. MA now owns 558,554 shares of the apparel and footwear maker’s stock worth $13,992,000 after purchasing an additional 5,746 shares in the last quarter. Matarin Capital Management LLC purchased a new position in Zumiez during the first quarter worth about $12,026,000. Finally, Renaissance Technologies LLC increased its holdings in Zumiez by 91.2% in the second quarter. Renaissance Technologies LLC now owns 465,900 shares of the apparel and footwear maker’s stock valued at $11,671,000 after buying an additional 222,200 shares in the last quarter. 75.87% of the stock is owned by hedge funds and other institutional investors.

Best Financial Stocks To Invest In Right Now: SL Green Realty Corporation(SLG)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of SL Green Realty Corp (NYSE:SLG) have been given an average recommendation of “Hold” by the eighteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation, six have given a hold recommendation and nine have given a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $111.54.

  • [By Joseph Griffin]

    Swiss National Bank lessened its stake in SL Green Realty (NYSE:SLG) by 13.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 315,900 shares of the real estate investment trust’s stock after selling 51,200 shares during the period. Swiss National Bank owned 0.35% of SL Green Realty worth $30,589,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SL Green Realty (SLG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Sterlingcoin (CURRENCY:SLG) traded flat against the dollar during the one day period ending at 9:00 AM Eastern on October 1st. In the last week, Sterlingcoin has traded 3.1% higher against the dollar. One Sterlingcoin coin can currently be purchased for about $0.0337 or 0.00000516 BTC on exchanges. Sterlingcoin has a market capitalization of $143,001.00 and approximately $0.00 worth of Sterlingcoin was traded on exchanges in the last 24 hours.

  • [By Ethan Ryder]

    Sterlingcoin (CURRENCY:SLG) traded flat against the US dollar during the one day period ending at 22:00 PM Eastern on August 24th. In the last week, Sterlingcoin has traded up 8.5% against the US dollar. One Sterlingcoin coin can currently be bought for approximately $0.0358 or 0.00000528 BTC on major exchanges. Sterlingcoin has a total market capitalization of $151,929.00 and approximately $5.00 worth of Sterlingcoin was traded on exchanges in the last 24 hours.

Best Financial Stocks To Invest In Right Now: Ishares Trust Dj Us Financial (IYF)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    The challenges facing EUFN may indicate the ETF will be challenged to deliver compelling risk-reward for investors. EUFN's three-year standard deviation is 18.23 percent, or more than 500 basis points above the same metric on the iShares U.S. Financials ETF (NYSE: IYF).

Best Financial Stocks To Invest In Right Now: KKR(KKR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Jeff Ubben’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben

    These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on KKR & Co Inc (KKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Benzinga News Desk]

    KKR & Co. (NYSE: KKR) will pay $8.3 billion to buy BMC Software, sources said — marking the buyout shop’s biggest acquisition in years: Link

  • [By Motley Fool Staff]

    KKR (NYSE:KKR) Q1 2018 Earnings Conference CallMay. 3, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Money Morning News Team]

    Recently, the large private equity firm KKR & Co. Inc. (NYSE: KKR) announced the purchase of Envision Healthcare Corp. (NYSE: EVHC). This acquisition has a $5.7 billion price tag, and the deal has a total value of $9.9 billion.

Best Financial Stocks To Invest In Right Now: Beneficial Mutual Bancorp Inc.(BNCL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Media coverage about Beneficial Bancorp (NASDAQ:BNCL) has trended positive recently, according to Accern. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Beneficial Bancorp earned a news impact score of 0.38 on Accern’s scale. Accern also gave media headlines about the bank an impact score of 45.8699493506664 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    Beneficial Bancorp Inc (NASDAQ:BNCL) Director Thomas J. Lewis sold 973 shares of the company’s stock in a transaction dated Wednesday, May 30th. The stock was sold at an average price of $16.50, for a total value of $16,054.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • [By Shane Hupp]

    TRADEMARK VIOLATION NOTICE: “FDx Advisors Inc. Purchases New Position in Beneficial Bancorp Inc (BNCL)” was published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at www.tickerreport.com/banking-finance/4202853/fdx-advisors-inc-purchases-new-position-in-beneficial-bancorp-inc-bncl.html.

Best Financial Stocks To Invest In Right Now: Greenlight Capital Re Ltd.(GLRE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Greenlight Capital Re (NASDAQ:GLRE) last issued its quarterly earnings results on Monday, April 30th. The financial services provider reported ($3.85) EPS for the quarter, beating the consensus estimate of ($4.43) by $0.58. Greenlight Capital Re had a negative return on equity of 23.81% and a negative net margin of 40.65%. The firm had revenue of $0.14 million during the quarter, compared to analysts’ expectations of $30.20 million. sell-side analysts forecast that Greenlight Capital Re, Ltd. will post -4.2 earnings per share for the current fiscal year.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Greenlight Capital Re (GLRE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Greenlight Capital Re (NASDAQ:GLRE) was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

Best Financial Stocks To Buy Right Now

Wall Street brokerages expect that Immunomedics, Inc. (NASDAQ:IMMU) will report ($0.20) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Immunomedics’ earnings, with the lowest EPS estimate coming in at ($0.31) and the highest estimate coming in at ($0.05). Immunomedics reported earnings per share of ($0.25) in the same quarter last year, which would indicate a positive year-over-year growth rate of 20%. The business is scheduled to announce its next earnings results on Wednesday, August 15th.

On average, analysts expect that Immunomedics will report full-year earnings of ($1.26) per share for the current financial year, with EPS estimates ranging from ($1.29) to ($1.24). For the next financial year, analysts anticipate that the business will post earnings of ($0.98) per share, with EPS estimates ranging from ($1.41) to ($0.57). Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow Immunomedics.

Best Financial Stocks To Buy Right Now: Colony Bankcorp Inc.(CBAN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Colony Bankcorp (NASDAQ:CBAN) have trended somewhat positive on Saturday, Accern Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Colony Bankcorp earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the financial services provider an impact score of 46.0420470648687 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Stephan Byrd]

    Media stories about Colony Bankcorp (NASDAQ:CBAN) have trended somewhat positive this week, according to Accern. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Colony Bankcorp earned a daily sentiment score of 0.02 on Accern’s scale. Accern also gave news stories about the financial services provider an impact score of 48.3992787299045 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Max Byerly]

    Media headlines about Colony Bankcorp (NASDAQ:CBAN) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Colony Bankcorp earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave news articles about the financial services provider an impact score of 46.5935973221915 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Best Financial Stocks To Buy Right Now: RenaissanceRe Holdings Ltd.(RNR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Kemper (NYSE: RNR) and RenaissanceRe (NYSE:RNR) are both mid-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

  • [By Logan Wallace]

    RenaissanceRe (NYSE: RNR) is one of 73 publicly-traded companies in the “Fire, marine, & casualty insurance” industry, but how does it compare to its rivals? We will compare RenaissanceRe to similar companies based on the strength of its dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

  • [By Logan Wallace]

    Kemper (NYSE: RNR) and RenaissanceRe (NYSE:RNR) are both mid-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

  • [By Ethan Ryder]

    Shares of RenaissanceRe Holdings Ltd. (NYSE:RNR) have earned an average recommendation of “Hold” from the nine ratings firms that are presently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $142.00.

  • [By Joseph Griffin]

    Rhumbline Advisers trimmed its position in shares of RenaissanceRe Holdings Ltd. (NYSE:RNR) by 8.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 74,399 shares of the insurance provider’s stock after selling 6,510 shares during the period. Rhumbline Advisers owned about 0.18% of RenaissanceRe worth $8,952,000 as of its most recent SEC filing.

Best Financial Stocks To Buy Right Now: Argo Group International Holdings Ltd.(AGII)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Argo Group (NASDAQ: AGII) and Stewart Information Services (NYSE:STC) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

  • [By Joseph Griffin]

    Barclays PLC raised its stake in Argo Group (NASDAQ:AGII) by 25.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,691 shares of the insurance provider’s stock after acquiring an additional 1,754 shares during the period. Barclays PLC’s holdings in Argo Group were worth $499,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Lord Abbett & CO. LLC purchased a new position in shares of Argo Group (NASDAQ:AGII) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 840,251 shares of the insurance provider’s stock, valued at approximately $48,230,000. Lord Abbett & CO. LLC owned approximately 2.49% of Argo Group as of its most recent filing with the SEC.

Best Financial Stocks To Buy Right Now: Territorial Bancorp Inc.(TBNK)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Territorial Bancorp Inc (NASDAQ:TBNK) have earned a consensus recommendation of “Hold” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $33.50.

  • [By Stephan Byrd]

    Territorial Bancorp Inc (NASDAQ:TBNK) Director David S. Murakami sold 4,394 shares of Territorial Bancorp stock in a transaction dated Monday, June 11th. The shares were sold at an average price of $30.67, for a total value of $134,763.98. Following the completion of the transaction, the director now owns 27,494 shares of the company’s stock, valued at approximately $843,240.98. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

  • [By Shane Hupp]

    BankFinancial (NASDAQ:BFIN) and Territorial Bancorp (NASDAQ:TBNK) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

  • [By Stephan Byrd]

    Shares of Territorial Bancorp (NASDAQ:TBNK) have been given an average rating of “Hold” by the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $33.50.

  • [By Stephan Byrd]

    Press coverage about Territorial Bancorp (NASDAQ:TBNK) has trended somewhat positive on Monday, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Territorial Bancorp earned a daily sentiment score of 0.14 on Accern’s scale. Accern also gave media coverage about the financial services provider an impact score of 45.0132105892291 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Best Financial Stocks To Buy Right Now: KKR(KKR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Recently, the large private equity firm KKR & Co. Inc. (NYSE: KKR) announced the purchase of Envision Healthcare Corp. (NYSE: EVHC). This acquisition has a $5.7 billion price tag, and the deal has a total value of $9.9 billion.

  • [By Max Byerly]

    Oppenheimer set a $35.00 target price on KKR & Co Inc (NYSE:KKR) in a report released on Wednesday morning. The firm currently has a buy rating on the asset manager’s stock.

  • [By Money Morning Staff Reports]

    This was not overlooked by Wall Street, either, as the giant private equity firm KKR & Co. LP (NYSE: KKR) bought Envision Healthcare Corp. (NYSE: EVHC) for $5.7 billion in cash, with the total deal value adding up to $9.9 billion including debt. It was one of the largest leveraged buyouts so far in 2018.

Best Financial Stocks To Buy Right Now: Infinity Property and Casualty Corporation(IPCC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ValuEngine lowered shares of Infinity Property and Casualty (NASDAQ:IPCC) from a strong-buy rating to a buy rating in a research report released on Saturday morning.

  • [By Stephan Byrd]

    Infinity Property and Casualty (NASDAQ:IPCC) and Hartford Financial Services Group (NYSE:HIG) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation.

  • [By Shane Hupp]

    Berkshire Hathaway Inc. Class B (NYSE: BRK.B) and Infinity Property and Casualty (NASDAQ:IPCC) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.

Best Financial Stocks To Watch Right Now

Equities analysts expect that Celestica Inc (NYSE:CLS) (TSE:CLS) will announce sales of $1.59 billion for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Celestica’s earnings, with the highest sales estimate coming in at $1.62 billion and the lowest estimate coming in at $1.57 billion. Celestica posted sales of $1.56 billion in the same quarter last year, which would indicate a positive year over year growth rate of 1.9%. The firm is scheduled to announce its next quarterly earnings report on Tuesday, July 24th.

On average, analysts expect that Celestica will report full year sales of $6.38 billion for the current financial year, with estimates ranging from $6.24 billion to $6.52 billion. For the next fiscal year, analysts expect that the firm will report sales of $6.72 billion per share. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that cover Celestica.

Best Financial Stocks To Watch Right Now: KKR(KKR)

Advisors’ Opinion:

  • [By Tim Melvin]

    Henry McVey, a macroeconomist over at KKR & Co. LP (NYSE: KKR) who’s been pretty accurate over the past few years, thinks we’ll see six more rate hikes in 2018 and 2019. Guggenheim Partners predicts a whopping seven rate hikes, which would put the federal funds rate at 3.50% by the end of 2019.

  • [By Chris Lange]

    Envision Healthcare Corp. (NYSE: EVHC) saw its shares make a slight bump early on Monday morning after it was announced that the firm would be acquired by KKR & Co. L.P. (NYSE: KKR). This deal was unanimously approved by Envisions Board of Directors.

  • [By Wayne Duggan]

    On this day 39 years ago, KKR & Co. L.P. Unit (NYSE: KKR) completed the first modern leveraged buyout of a public company, taking over manufacturer Houdaille Industries for $355 million.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KKR & Co. L.P. (KKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KKR & Co. L.P. Unit (KKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Tim Melvin]

    I’m talking about private equity behemoth KKR & Co. LP (NYSE: KKR) buying Envision Healthcare Corp. (NYSE: EVHC) for $5.7 billion in cash, with the total deal value adding up to $9.9 billion including debt. This marks one of the largest leveraged buyouts of 2018.

Best Financial Stocks To Watch Right Now: The First of Long Island Corporation(FLIC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on First of Long Island (FLIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Financial Stocks To Watch Right Now: Ishares Trust Dj Us Financial (IYF)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    The challenges facing EUFN may indicate the ETF will be challenged to deliver compelling risk-reward for investors. EUFN's three-year standard deviation is 18.23 percent, or more than 500 basis points above the same metric on the iShares U.S. Financials ETF (NYSE: IYF).

Best Financial Stocks To Watch Right Now: Prudential Public Limited Company(PUK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ValuEngine lowered shares of Prudential (NYSE:PUK) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning.

    Several other analysts have also recently issued reports on the stock. Zacks Investment Research upgraded shares of Prudential from a hold rating to a buy rating and set a $57.00 target price on the stock in a research note on Tuesday, March 27th. Berenberg Bank cut shares of Prudential from a hold rating to a sell rating in a research note on Thursday, March 29th. Finally, Citigroup cut shares of Prudential from a buy rating to a neutral rating in a research note on Wednesday, April 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The stock currently has an average rating of Hold and an average price target of $57.00.

  • [By Ethan Ryder]

    Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

  • [By Stephan Byrd]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Prudential alerts:

    Zacks Investment Research Lowers Prudential (PUK) to Hold (americanbankingnews.com) Financial wellness program popularity rises among employers, up 63 percentage points in two years (markets.financialcontent.com) FY2018 EPS Estimates for Prudential (PUK) Reduced by Jefferies Group (americanbankingnews.com) Jefferies Group Weighs in on Prudential’s FY2020 Earnings (PUK) (americanbankingnews.com) ValuEngine Downgrades Prudential (PUK) to Hold (americanbankingnews.com)

    Shares of PUK stock traded down $0.02 during trading on Tuesday, hitting $51.56. 141,455 shares of the stock traded hands, compared to its average volume of 198,097. The firm has a market cap of $66.49 billion, a PE ratio of 13.79, a PEG ratio of 1.34 and a beta of 1.55. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.03 and a current ratio of 0.03. Prudential has a 52-week low of $44.49 and a 52-week high of $55.36.

Best Financial Stocks To Watch Right Now: INTL FCStone Inc.(INTL)

Advisors’ Opinion:

  • [By Shane Hupp]

    INTL FCStone (NASDAQ:INTL) was upgraded by investment analysts at TheStreet from a “c” rating to a “b-” rating in a note issued to investors on Monday.

  • [By Max Byerly]

    INTL FCStone (NASDAQ:INTL) shares reached a new 52-week high and low during trading on Monday . The company traded as low as $47.87 and last traded at $47.95, with a volume of 2050 shares trading hands. The stock had previously closed at $47.30.

  • [By Logan Wallace]

    INTL FCStone (NASDAQ:INTL) released its earnings results on Tuesday. The financial services provider reported $1.18 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.98 by $0.20, Bloomberg Earnings reports. INTL FCStone had a positive return on equity of 3.32% and a negative net margin of 0.02%.

  • [By Joseph Griffin]

    Dimensional Fund Advisors LP trimmed its stake in shares of INTL Fcstone Inc (NASDAQ:INTL) by 1.3% during the first quarter, Holdings Channel reports. The fund owned 877,501 shares of the financial services provider’s stock after selling 11,320 shares during the quarter. Dimensional Fund Advisors LP’s holdings in INTL Fcstone were worth $37,452,000 as of its most recent SEC filing.

Best Financial Stocks To Watch Right Now: Gladstone Commercial Corporation(GOOD)

Advisors’ Opinion:

  • [By Max Byerly]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its genesis date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

  • [By Shane Hupp]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its launch date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

Hot Medical Stocks To Own For 2019

Oncobiologics (NASDAQ: ONS) and CytRx (NASDAQ:CYTR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Insider and Institutional Ownership

Get Oncobiologics alerts:

11.5% of Oncobiologics shares are owned by institutional investors. Comparatively, 4.7% of CytRx shares are owned by institutional investors. 33.5% of Oncobiologics shares are owned by company insiders. Comparatively, 5.3% of CytRx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and target prices for Oncobiologics and CytRx, as provided by MarketBeat.

Hot Medical Stocks To Own For 2019: First Commonwealth Financial Corporation(FCF)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on First Commonwealth Financial (FCF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on First Commonwealth Financial (FCF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Barclays PLC increased its holdings in First Commonwealth Financial (NYSE:FCF) by 24.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 33,717 shares of the bank’s stock after buying an additional 6,593 shares during the period. Barclays PLC’s holdings in First Commonwealth Financial were worth $476,000 as of its most recent SEC filing.

Hot Medical Stocks To Own For 2019: Equinix Inc.(EQIX)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is one of the larger cap companies in the data center arena and a top play for more conservative accounts. Equinix Inc. (NASDAQ: EQIX) provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Equinix (EQIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Credit Suisse Group set a $525.00 price objective on Equinix (NASDAQ:EQIX) in a research report report published on Friday. The firm currently has a buy rating on the financial services provider’s stock.

  • [By Lee Jackson]

    This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX)provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

Hot Medical Stocks To Own For 2019: Jack Henry & Associates Inc.(JKHY)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Whittier Trust Co. of Nevada Inc. raised its position in Jack Henry & Associates (NASDAQ:JKHY) by 42.5% in the first quarter, Holdings Channel reports. The fund owned 3,154 shares of the technology company’s stock after buying an additional 940 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Jack Henry & Associates were worth $381,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Stifel Financial Corp increased its position in Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 12.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,616 shares of the technology company’s stock after acquiring an additional 6,990 shares during the period. Stifel Financial Corp’s holdings in Jack Henry & Associates were worth $7,436,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Jack Henry & Associates (JKHY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Own For 2019: KKR(KKR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Jeff Ubben’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben

    These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,

  • [By Tim Melvin]

    Much of my investing philosophy today was learned by studying KKR & Co. LP (NYSE: KKR), Bain Capital, and other private equity firms.

    Most of the firms collect a 2% management fee and a 20% incentive fee on realized profits.

  • [By ]

    In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .

Hot Medical Stocks To Own For 2019: Polaris Industries Inc.(PII)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Polaris Industries (PII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    SevenBridge Financial Group LLC lowered its stake in shares of Polaris Industries Inc. (NYSE:PII) by 31.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,432 shares of the company’s stock after selling 1,129 shares during the quarter. SevenBridge Financial Group LLC’s holdings in Polaris Industries were worth $279,000 at the end of the most recent reporting period.

  • [By Rich Duprey]

    What’s at stake is more than just bragging rights about which motorcycle company has the better racing team. In an industry suffering from flagging sales, race results highlight each bike maker’s technology, innovation, and prowess in building a top performance machine. And that could help provide an edge at dealerships. With Harley once again falling behind Indian’s ownerPolaris Industries (NYSE:PII) in the early going, it could give Indian the momentum to keep driving sales higher.

Hot Medical Stocks To Own For 2019: EMCORE Corporation(EMKR)

Advisors’ Opinion:

  • [By Max Byerly]

    News stories about EMCORE (NASDAQ:EMKR) have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. EMCORE earned a news sentiment score of 0.10 on Accern’s scale. Accern also gave media stories about the semiconductor company an impact score of 45.6118508960632 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is themostshorted stock on theNASDAQ with short interest of 62.65% according to Highshortnterest.com.

Top 5 Value Stocks To Buy For 2018

Oppenheimer set a $120.00 target price on Neurocrine Biosciences (NASDAQ:NBIX) in a report published on Monday morning. The brokerage currently has a buy rating on the stock. Oppenheimer also issued estimates for Neurocrine Biosciences’ FY2021 earnings at $7.03 EPS and FY2022 earnings at $7.88 EPS.

Several other research analysts have also commented on the company. ValuEngine raised Neurocrine Biosciences from a hold rating to a buy rating in a research report on Monday, April 2nd. BidaskClub downgraded Neurocrine Biosciences from a strong-buy rating to a buy rating in a research note on Tuesday, March 20th. Leerink Swann boosted their target price on Neurocrine Biosciences from $90.00 to $96.00 and gave the stock an outperform rating in a research note on Tuesday, February 20th. JPMorgan Chase boosted their target price on Neurocrine Biosciences from $79.00 to $100.00 and gave the stock an overweight rating in a research note on Wednesday, February 14th. Finally, Barclays restated an overweight rating and set a $100.00 target price on shares of Neurocrine Biosciences in a research note on Wednesday, February 14th. Thirteen analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $102.77.

Top 5 Value Stocks To Buy For 2018: KKR(KKR)

Advisors’ Opinion:

  • [By ]

    Kohlberg Kravis Roberts (KKR) : “I’m a buyer. I’ve respected them for generations. “

    Mitek Systems (MITK) : “This one is too speculative for me. I’d buy NVIDIA (NVDA) .”

  • [By Wayne Duggan]

    On this day 39 years ago, KKR & Co. L.P. Unit (NYSE: KKR) completed the first modern leveraged buyout of a public company, taking over manufacturer Houdaille Industries for $355 million.

  • [By ]

    In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .

  • [By Motley Fool Staff]

    KKR (NYSE:KKR) Q1 2018 Earnings Conference CallMay. 3, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Value Stocks To Buy For 2018: Steelcase Inc.(SCS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the media stories that may have impacted Accern’s rankings:

    Get Steelcase alerts:

    Vida Health Expands Platform to Tackle Comorbidities (prweb.com) Zacks: Brokerages Expect Steelcase (SCS) Will Announce Quarterly Sales of $756.45 Million (americanbankingnews.com) Knoll: Q1 Earnings Enough To Stay Long (seekingalpha.com) ValuEngine Downgrades Steelcase (SCS) to Sell (americanbankingnews.com) Should Stem Cells Spin SA.s (WSE:SCS) Recent Earnings Decline Worry You? (finance.yahoo.com)

    Several research analysts have weighed in on the company. ValuEngine lowered Steelcase from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Seaport Global Securities reaffirmed a “neutral” rating on shares of Steelcase in a research report on Monday, March 26th. Finally, Zacks Investment Research raised Steelcase from a “sell” rating to a “hold” rating in a research report on Wednesday, March 28th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $16.00.

  • [By Stephen Mack]

    Jim Hackett spent two decades as CEO of Michigan-based office furniture company Steelcase Inc. (NYSE: SCS). When he took over, the American workplace was shifting away from cubicles, and the company looked on the verge of extinction, with $70 million in annual losses.

  • [By Ethan Ryder]

    SpeedCash (CURRENCY:SCS) traded 13.6% lower against the dollar during the 1 day period ending at 10:00 AM ET on May 4th. One SpeedCash coin can now be purchased for approximately $2.71 or 0.00028080 BTC on major exchanges including YoBit, Cryptohub, Trade Satoshi and Crex24. During the last seven days, SpeedCash has traded 201.8% higher against the dollar. SpeedCash has a total market capitalization of $1.26 million and $26,755.00 worth of SpeedCash was traded on exchanges in the last 24 hours.

  • [By Max Byerly]

    SpeedCash (SCS) is a coin. SpeedCash’s total supply is 476,918 coins and its circulating supply is 467,791 coins. The Reddit community for SpeedCash is /r/SpeedCash and the currency’s Github account can be viewed here. SpeedCash’s official Twitter account is @SpeedCashMedia. SpeedCash’s official website is www.scash.ml.

Top 5 Value Stocks To Buy For 2018: Two Harbors Investments Corp(TWO)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By Logan Wallace]

    HL Financial Services LLC purchased a new position in shares of Two Harbors Investment (NYSE:TWO) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 53,436 shares of the real estate investment trust’s stock, valued at approximately $821,000.

  • [By Matthew Frankel]

    Mortgage real estate investment trust CYS Investments (NYSE:CYS) announced today that it had agreed to be acquired by fellow mortgage REIT Two Harbors Investment (NYSE:TWO).

Top 5 Value Stocks To Buy For 2018: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Dustin Blitchok]

    The European Union’s General Data Protection Regulation takes effect May 25, and Steve Sanders, the executive vice president of marketing and product development at Interactive Brokers (NASDAQ: IBKR), described it as the “bane of my existence.” Compliance with the regulations is taking resources from other products at the online brokerage, he said.

Top 5 Value Stocks To Buy For 2018: Immersion Corporation(IMMR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Stephan Byrd]

    Wells Fargo & Company MN reduced its stake in shares of Immersion Co. (NASDAQ:IMMR) by 67.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,010 shares of the software maker’s stock after selling 36,839 shares during the quarter. Wells Fargo & Company MN owned approximately 0.06% of Immersion worth $127,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Shares of Immersion Co. (NASDAQ:IMMR) reached a new 52-week high and low during trading on Friday following a stronger than expected earnings report. The stock traded as low as $13.05 and last traded at $12.34, with a volume of 86458 shares trading hands. The stock had previously closed at $13.21.

  • [By Shane Hupp]

    Here are some of the news headlines that may have impacted Accern’s analysis:

    Get Immersion alerts:

    Turtle Beach (HEAR) and Immersion (IMMR) Are Aggressive Growth Stocks (finance.yahoo.com) Immersion (IMMR) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com) Is the Options Market Predicting a Spike in Immersion (IMMR) Stock? (zacks.com) Immersion (IMMR) vs. Radisys (RSYS) Head-To-Head Review (americanbankingnews.com) Stock Traders Purchase High Volume of Immersion Put Options (IMMR) (americanbankingnews.com)

    Immersion opened at $13.76 on Friday, according to Marketbeat. Immersion has a 12 month low of $13.32 and a 12 month high of $13.55. The firm has a market cap of $422.28 million, a P/E ratio of -11.56, a P/E/G ratio of 0.53 and a beta of 1.22.